I am not a technical chartist, more basing my stock selection on fundamental analysis. However I do believe there is a place for TA, and thus I tend to watch and follow trading momentum, as an indicator of what the market's view is of a particular stock.
It is my view that EBR has excellent long term prospects, despite a very poor start from IPO, with a list price of $1.08 in Nov 2021, and dropping to as low as $0.33 in June 2022. It has since recovered somewhat as the SOLVE trial has progressed.
I'm interested to know if there are any TA followers who would like to add their views on this forum, negative or positive.
Note that the stock is reasonably illiquid, with limited trading volume, which IMO facilitates share price manipulation. Interestingly I've noticed continual (successful) attempts to cap the price - for example last week when the share price moved into the low 60's all of a sudden a sell order of 75,000 shares Offered at 62 cents, which managed to keep a lid on the price, and a mini-dump followed (with the low on the day about 53.5, of less than 1,000 shares!). Today there's a 100,000 shares Offered at 71 cents!
- Forums
- ASX - By Stock
- EBR
- Charting
Charting
-
- There are more pages in this discussion • 369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.02 |
Change
0.000(0.00%) |
Mkt cap ! $385.7M |
Open | High | Low | Value | Volume |
$1.03 | $1.05 | $1.02 | $65.61K | 63.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 102 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6967 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 102 | 1.020 |
1 | 7211 | 1.015 |
1 | 18027 | 1.010 |
1 | 2680 | 1.000 |
1 | 13 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.040 | 5947 | 2 |
1.045 | 16000 | 1 |
1.050 | 11277 | 1 |
1.060 | 9000 | 1 |
1.090 | 13160 | 2 |
Last trade - 11.39am 12/11/2024 (20 minute delay) ? |
Featured News
EBR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online